Press Releases 2024

PDF DOWNLOAD VIEW ALL NEWS

Announces Acquisition Of Pre-1954 Pharmacy Charter

Toronto, ON – April 26, 2024 – LevelJump Healthcare Corp. (TSXV: JUMP) (OTC: JMPHF) (FSE: 75J) (“LevelJump” or the “Company”), a Canadian leader in B2B telehealth solutions, is pleased to announce that it has entered an agreement to acquire a pre-1954 pharmacy charter corporation (“Pharmacy License”).

The Company has agreed to purchase the Pharmacy License for $1,900,000, to be paid as $1,800,000 in cash and 100,000 shares of JUMP preferred shares. To date a deposit of $50,000 has been paid. Closing is targeted for the second quarter and is subject to funding and any necessary regulatory consents.

“We are very excited to acquire this license and be able to begin integrating pharmacy services into our teleHopsital portal.” Mitch Geisler, CEO. “By integrating these services with our planned primary care services through teleHospital, and coupled with our diagnostic imaging services, we expect to be able to deliver a full health care package to all of our portal patients and increase the revenues and profitability of our new portal.”

JUMP is expecting to be able to launch the beta version of teleHospital portal in the third quarter of 2024.

About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centers. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.


ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer

Caitlin-Robyn Densmore
Business Development Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.